Monitoring Continuum
description
Transcript of Monitoring Continuum
![Page 1: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/1.jpg)
![Page 2: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/2.jpg)
![Page 3: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/3.jpg)
Monitoring Continuum
![Page 4: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/4.jpg)
ISSUE-3
![Page 5: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/5.jpg)
Atrial Fibrillation Classification
![Page 6: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/6.jpg)
Cryptogenic Stroke and Atrial Fibrillation
![Page 7: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/7.jpg)
AF Management GuidelinesConsiderations for Anticoagulant
Selection
![Page 8: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/8.jpg)
SURPRISE TRIAL
![Page 9: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/9.jpg)
Time from Cryptogenic Stroke to AF Detection by ICMResults from SURPRISE study
![Page 10: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/10.jpg)
CRYSTAL AF
![Page 11: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/11.jpg)
Atrial Fibrillation Duration in ICM Arm at 12 Months (N = 29)
![Page 12: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/12.jpg)
Feedback Loop for Care Team
![Page 13: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/13.jpg)
Clinical ScenarioPresentation and Work-up
![Page 14: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/14.jpg)
Evaluation for Cryptogenic Stroke
![Page 15: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/15.jpg)
Clinical ScenarioContinuous Monitoring
![Page 16: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/16.jpg)
Current and Emerging Indications for Implantable Cardiac Monitoring
![Page 17: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/17.jpg)
AF Burden During Blanking Period Predicts Response to RFA at 12
Months
![Page 18: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/18.jpg)
DISCERN AFProspective Multicenter Study
![Page 19: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/19.jpg)
Abbreviations
![Page 20: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/20.jpg)
Abbreviations (cont)
![Page 21: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/21.jpg)
References
![Page 22: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/22.jpg)
References (cont)
![Page 23: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/23.jpg)
References (cont)
![Page 24: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/24.jpg)
References (cont)
![Page 25: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/25.jpg)
References (cont)
![Page 26: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/26.jpg)
References (cont)
![Page 27: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/27.jpg)
References (cont)
![Page 28: Monitoring Continuum](https://reader033.fdocuments.us/reader033/viewer/2022061504/56815b5a550346895dc9429e/html5/thumbnails/28.jpg)
References (cont)